SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: erin4 who wrote (2890)5/20/1999 10:21:00 PM
From: Spekulatius  Read Replies (1) | Respond to of 10280
 
I wonder if the falling stock price and the announcement of SGP to fight for an extended patent life for claritin is just a coincidence. If the patent is extended, is SGP still willing to put Claritin II to market and pay royalities to SEPR?
Since Claritin is one of the most important drugs for SEPR this is a very important question.